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Box 1. HF [18_TD$DIFF]Pigmentation
Among the various cells that comprise the HF, the relevant differences seen in gene expression betweenForum
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The unravelling of hair pigmenta-
tion genetics and robust delivery
systems to the hair follicle (HF) will
allow the development of a new
class of colouring products. The
challenge will be changing hair col-
our from inside out by safely regu-
lating the activity of target genes
through the speciﬁc delivery of
synthetic/natural compounds, pro-
teins, genes, or small RNAs.pigmented and grey HFs can be related to melanocyte biology (Table I and Figure I). Microarray analysis is a
powerful technique that allows a global perspective on what is occurring in a cell, tissue, or organism at a
particular moment through the comparison of the levels of all mRNAs corresponding to the genes being
expressed: the transcriptome. Such analysis was conducted by a research group on pigmented and white
human HFs [12].
Table I. Mean [8_TD$DIFF] old [9_TD$DIFF]Changes in the [10_TD$DIFF]Expression of a [11_TD$DIFF]Selected [12_TD$DIFF]Group of [13_TD$DIFF]Genes that were
[14_TD$DIFF]Upregulated in [15_TD$DIFF]Pigmented HFs [16_TD$DIFF]Compared with [17_TD$DIFF]White HFs [8]
Gene Symbol Gene Name Mean Fold Change
TYRP1 Tyrosinase-related protein 1 116.58
SILV Silver homologue (mouse) 36.21
TYR Tyrosinase (oculocutaneous albinism IA) 26.36
MLANA Melan-A 25.02
TRPM1 Transient receptor potential cation channel, subfamily M,
member 1
8.58
SLC45A2 Solute carrier family 45, member 2 5.21
GPR143 G protein-coupled receptor 143 3.88
CAPN3 Calpain 3 (p94) 3.68
PLXNC1 Plexin C1 3.64
KIT v-kit Hardy–Zuckerman 4 feline sarcoma viral oncogene
homologue
2.81
PAX3 Paired box 3 2.23
OLFM1 Olfactomedin 1 2.06
MET Met proto-oncogene (hepatocyte growth factor receptor) 2.04
HPS1 Hermansky–Pudlak syndrome 1 1.86
OSTM1 Osteopetrosis-associated transmembrane protein 1 1.66
EDNRB Endothelin receptor type B 1.65Genetics of HF Pigmentation and
Greying
Pigmentation is one of the most striking
phenotypic traits in humans. It has great
social and psychological relevance and
the possibility of controlling it has
immense resonance for any individual or
ethnic group. The colour of human hair,
skin, and eyes is determined by the
amount, type, and tissue distribution of
melanin. Melanin is a complex mixture of
pigmented indole-rich biopolymers that
are synthesised by specialised cells called
melanocytes. The main types of melanin
polymer are the black-to-brown eumela-
nin (highly polymerised) and the yellow-
to-reddish-brown pheomelanin (lighter,
less polymerised, and containing sulfur)
[1]. Black hair has the highest eumelanin-
to-pheomelanin ratio while red-to-yellow
hairs have the lowest ratio; grey or white
hairs have insigniﬁcant or nomelanin at all.
For more information on melanin produc-
tion by melanocytes, see Box 1.
Pigment synthesis, storage, and transport
occur in lysosome-related organelles
known as melanosomes. Although thebiochemical synthesis of melanin is com-
mon to all pigmented tissues, melanogen-
esis is regulated differently among them. In
hair, melanogenesis occurs only during
the anagen (active growth) phase of the
hair growth cycle in melanocytes located
exclusively in the hair bulb, while in skin, for
instance, melanin is constitutively pro-
duced. An interesting study [2] demon-
strated that [19_TD$DIFF]a SNP previously associated
with blond hair in northern Europeans is
responsible for a 20% [20_TD$DIFF] reduction in the
activity of a tissue-speciﬁc regulatory
enhancer affecting KITLG gene transcrip-
tion in the HF only. Different regulatory
mechanisms underlie the discrepancy
between the pigmentation phenotypes
of hair, skin, and eyes commonly seen
in an individual. Knowing how to interferewith melanogenesis in a tissue-speciﬁc
manner will thus be an invaluable cosmetic
tool.
Several approaches have contributed to
identifying genes involved in melanin syn-
thesis and in the biogenesis, transport,
and distribution of melanosomes, as well
as genes regulating those processes
(Box 1) [3,4]. These approaches include
comparative genomics of candidate genes
such as those identiﬁed in animal models.
By October 2011, the International Feder-
ation of Pigment Cell Societies database
had described 378 putative pigmentation
loci for mice and their human and zebraﬁsh
homologues (http://www.espcr.org/
micemut/). Despite the many genes
already implicated inmelanogenesis, thoseTrends in Biotechnology, Month Year, Vol. xx, No. yy 1
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Figure I. [3_TD$DIFF]Melanocyte Function in HF Pigmentation. (A) Schematic drawing of a pigmented and a grey [4_TD$DIFF]HF, where some structures and cells are highlighted. (B)
Differentiated melanocyte showing its typical cellular processes and some of the most frequently associated genes. (C) Biochemical synthesis of both types of melanin,
which occurs inside specialised organelles called melanosomes [5_TD$DIFF]. Abbreviation: HF, hair folicle.associated with natural human hair colour
variation are rather few [4]. A research
group has created a model with very good
predictive accuracy for hair-colour2 Trends in Biotechnology, Month Year, Vol. xx, No. yycategories based on no more than 45
SNPs related to only 12 different genes
[5]. We think that the already reported
genes, included those in the hair-colourprediction model, are an excellent starting
point to develop cosmetic strategies to
modulate gene activities, changing hair col-
our from the follicle (Box 2). However, any
TIBTEC 1306 No. of Pages 5
Box 2. New Cosmetics
The necessary conditions to start a new era in hair cosmetics are now being met. In the available state of the art, a relevant group of genes and their respective proteins
were identiﬁed whose activities, when altered by DNA polymorphisms, are associated with a particular natural colour of hair within a human population. However, in
past decades researchers have accomplished important advances in the development of speciﬁc nanocarriers for HF delivery. The combination of the acquired
knowledge will soon allow the safe and speciﬁc delivery of molecules capable of modelling the activity of these genes and their proteins in the cells of the hair bulb,
simulating what occurs in the presence of DNA polymorphisms (Figure I).
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Figure I. Scheme for [6_TD$DIFF] nnovative Approaches to Hair Coloration[7_TD$DIFF] Based on the Modulation of Genes.gene acting directly or indirectly in melano-
genesis is a potential candidate.
The cellular mechanisms that synchronise
melanin synthesis with the active growthphase of the HF remain unclear. Hair grey-
ing represents the striking uncoupling of
those two events. Intense research on hair
greying indicates age-related oxidative
stress in the HF [6,7]. Oxidative stressresults from an imbalance between the
production of reactive oxygen species
(ROS) and their neutralisation. ROS are
produced during normal cell metabolism
(melanin production involves massiveTrends in Biotechnology, Month Year, Vol. xx, No. yy 3
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nously by exposure to UV, pollution,
inﬂammation, or even emotional stress
[7]. The loss of pigment from the scalp
HFs is therefore a direct consequence
of the shutdown of melanin synthesis,
as conﬁrmed by comparative transcrip-
tome analysis between grey and pig-
mented HFs (Box 1). This shutdown can
have several causes acting at different
levels and HF locations [6,7], coordinately
or independently: (i) cessation of melanin
production; (ii) apoptosis of follicular differ-
entiated melanocytes; and (iii) incapacity
to maintain the homeostasis of the mela-
nocyte stem cell niche.
The key observation common to all of
these processes is oxidative damage. It
is unclear whether this damage is a cause
or a consequence of an ‘earlier’-acting
element determining the timing of hair
greying, often a heritable trait. If it exists,
this element must be genetic in nature.
The varying susceptibility of melanocytes
to oxidative stress within the HF and the
independent ageing of HFs throughout
the scalp and body indicate a high level
of autonomous physiological regulation
[6]. The particular crosstalk between mel-
anocytes– keratinocytes and melano-
cytes–dermal papilla cells in scalp HFs
must be important in determining the
faster ageing of scalp HFs compared with
HFs elsewhere. We believe that in the near
future the molecular basis of the cellular
events behind hair greying will be deci-
phered. The ongoing identiﬁcation of
molecular targets will allow the develop-
ment of efﬁcient antigreying cosmetics.
HFs as a Target for Nanodelivery
Systems
The HF is a privileged target for topical
delivery. The components of nano/micro-
delivery systems are known to accumulate
preferentially in HFs compared with else-
where in the skin. Bioeffective doses
of compounds can be efﬁciently delivered
to HFs [8,9]. Strategies under develop-
ment almost invariably include drug4 Trends in Biotechnology, Month Year, Vol. xx, No. yyencapsulation since it presents advan-
tages over direct application of free drugs.
Nanosized carriers address two relevant
points in HF-targeted drug delivery [9]:
increased guidance into HFs (reducing
the exposure of non-target tissues and
skin irritation) and increased retention
(signifying fewer applications and less-
prolonged exposure to the drug). Tuning
the physicochemical characteristics of
particles allows the control of their pene-
tration depth, protects encapsulated
molecules from degradation (particularly
high-molecular-weight molecules like pro-
teins or nucleic acids), and improves for-
mulation aesthetics and product stability.
In practice, cosmetic care routines are
performed repeatedly (several times per
week); therefore, continuously applying
and retaining an active ingredient in the
HF to fulﬁl its purpose is feasible.
The most common types of nanocarriers
for drug delivery to HFs include polymeric
and liposomal aggregates (Box 2). Poly-
mer-based micro/nanoparticles are the
most interesting for HF delivery because
of their more advantageous features:
higher ﬂuidity, more pleasant touch, trans-
parency, and a non-oily sensation that is
desirable for a leave-on hair-care product.
The speciﬁc delivery to the hair bulb of a
reporter gene in a liposome formulation
was successfully demonstrated in 1995,
by Lingna Li and Robert Hoffman, as a
model for HF gene therapy. Since then,
the HF has gained the attention of the
scientiﬁc community as a target per se
[10]. The range of macromolecules inter-
esting for HF therapies is continuously
growing and includes growth factors, sig-
nalling molecules, peptides, and antioxi-
dant enzymes [9]. Despite having a
therapeutic purpose [8], we consider that
all of the acquired knowledge can be
translated to the development of new cos-
metic approaches for hair care, centred on
its live component: the follicle. The clariﬁ-
cation of melanosome-transfer mecha-
nisms to keratinocytes and the
identiﬁcation of the molecular players
involved in their recognition by thekeratinocyte cell membrane will allow the
design of nanosystems speciﬁcally target-
ing keratinocytes to supply melanin efﬁ-
ciently and directly to a greying HF,
recycling an old idea by Lingna Li and
Robert Hoffman (1993).
The Future of Hair Care: Topical
Modulation of HF Biology
Greying reversal will most probably require
that undifferentiated melanocytes be
recruited to the HF matrix and activated,
as cyclically occurs on normal new, pig-
mented HF formation. There is evidence
that, in grey HFs, there is a population of
amelanotic melanocytes located at the
outer root sheath [6,7]. As indicated by
others, the fact that differentiated follicular
melanocytes are not associated with mel-
anoma suggests that greying is a protec-
tive mechanism and care must be taken
when developing antigreying strategies.
However, unintentional greying reversal,
as consequence of clinical chemical or
physical therapeutics or inﬂammation,
puts the subject into a new perspective.
We believe that, if early events responsible
for the maintenance and differentiation of
the stem pool of melanocytes are clearly
identiﬁed, it will become possible, by sup-
plying the appropriate stimuli to the follicle,
to activate a cascade of events that will
culminate in the safe recruitment of active
melanocytes to the HF matrix during the
transition to a new hair cycle. Obviously, it
would be preferable if hair-greying reversal
could occur immediately after the applica-
tion of a formulation, regardless of the hair
cycle stage. The migration of melanocytes
in an already formed follicle would not be
as easy but is possible, since these cells
are capable of movement as seen in vitro
and in vitiligo treatment. We believe that, in
the future, it will be possible and safe to
recruit undifferentiated melanocytes to
repopulate the hair bulb and to produce
pigment. Taking into account published
works, induction of tyrosinase (Tyr), the
major enzyme responsible for melanin
production, stability and activity, as well
as the exogenous application to HFs of
TIBTEC 1306 No. of Pages 5protective antioxidant enzymes (e.g., cata-
lase, superoxidedismutase)or antioxidants
(e.g., curcumin) toprotectmelanin-produc-
ing melanocytes from ROS generation, is
also a feasible approach.
The ability to regulate gene activity through
small RNA oligonucleotides has opened a
new range of opportunities for hair care
and treatment. Topical delivery of miRNAs
or siRNAs, naked or formulated, has
become feasible [9]. The recent work of
Hardman et al. describes the stimulation
of human melanogenesis in ex vivo HFs
and in vitro cultured HF melanocytes by
siRNA silencing of two molecular clock
genes associated with ROS homeostasis,
BMAL1 and PER1 [11].
Changing the colour of a pigmented hair
will require not the differentiation or move-
ment of melanocytes but ‘only’ redirecting
a biochemical pathway towards enrich-
ment in one of the possible products.
The modulation of natural hair colour by
interfering with gene activity in the follicle
is, in our opinion, a promising and as-yet-
unexplored ﬁeld of hair-care research. As
clearly demonstrated in vivo by Guenther
et al. [2], small reductions in the activity of a
HF-speciﬁc enhancer were sufﬁcient to
change the mouse coat phenotype. This
is an extremely important ﬁnding for future
cosmetic applications, such amodest var-
iation in gene expression levels being suf-
ﬁcient to cause a visible phenotypic
change. We expect that producing a for-
mulation speciﬁc for HF delivery of siRNA
against the KITLG gene will affect human
hair colour in the same way, shifting it to a
lighter shade.In terms of natural hair-colour modulation,
in our opinion it would be important to
decipher the 3D structure of Tyr and tyros-
inase-related protein 1 (Tyrp1). Since Tyr
is the key enzyme in melanogenesis and
the total amount of melanin is dependent
on its activity and stability, and since Tyrp1
expression is important for Tyr stability, a
drug-design approach could be under-
taken to speciﬁcally inhibit Tyrp1 catalytic
activity without affecting either its expres-
sion or the catalytic activity of Tyr. Tyr catal-
yses the synthesis of dopaquinone, a key
precursor of both eumelanin and pheome-
lanin. While eumelanogenesis requires the
direct intervention of two other enzymes,
Tyrp1 and Tyrp2, pheomelanogenesis
requires only the initial activity of Tyr. By
inhibiting Tyrp1, we would expect a shift
towards pheomelanin synthesis and there-
fore a lighter shade of hair colour.
Hair colour science is experiencing excit-
ing times; we expect promising ﬁndings
for hair care that only a few years ago
seemed like science ﬁction.
Concluding Remarks
Innovative hair care will be grounded in the
most recent advances in HF biology and in
follicle-targeted delivery for the develop-
ment of new products that consumers can
safely use at home. Major challenges
remain, however: the complete under-
standing how to interfere with the eume-
lanin-to-pheomelanin ratio at the genetic
level and the efﬁcient delivery of molecules
to HF cells to safely modulate gene activ-
ity. Overcoming those limitations will, in
our opinion, take hair care to a new level:
changing hair colour from inside out.Acknowledgments
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